Brighton Jones’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCRX
JHC
Brighton Jones's BCRX Position: Q3 2026 in Review
Brighton Jones sold out of BioCryst Pharmaceuticals (BCRX) in Q3 2026, closing a stake of 16,926 shares — an estimated $169K sold.
Brighton Jones first reported a position in BCRX in Q2 2026 and held it in 1 quarter. The position peaked at $169K in Q2 2026. 264 funds tracked by Wall St. Rank hold BCRX as of Q3 2026.
- Brighton Jones reported no remaining BioCryst Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 16,926 BioCryst Pharmaceuticals shares in Q3 2026, an estimated $169K.
- Brighton Jones first reported a position in BioCryst Pharmaceuticals in Q2 2026 and held it in 1 quarter.
- Brighton Jones's BioCryst Pharmaceuticals position peaked at $169K in Q2 2026.
- 264 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.